Smruthi Organic

Why is Smruthi Organics Ltd falling/rising?

As of 31-Aug, Smruthi Organics Ltd's stock price is rising to 142.15, with a notable increase of 25.85% over the past month. Despite a significant drop in investor participation, the stock remains above key moving averages, indicating a strong bullish trend.

As of 31-Aug, Smruthi Organics Ltd's stock price is rising, currently at 142.15, reflecting a change of 2.4 (1.72%) upward. The stock has shown strong performance over various periods, with a notable increase of 25.85% over the past month, significantly outperforming the Sensex, which declined by 1.46% during the same timeframe. Additionally, the stock has outperformed its sector by 2.07% today.<BR><BR>Intraday, the stock reached a high of Rs 143.65, indicating positive momentum, although it also experienced a low of Rs 132.6. Despite this fluctuation, the overall trend remains upward as Smruthi Organics is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong bullish trend.<BR><BR>However, it is important to note that there has been a significant drop in investor participation, with delivery volume on 28 August falling by 84.93% compared to the 5-day average. This decline in trading volume could indicate a potential concern for future price stability, but the current rise in stock price is primarily supported by its recent strong performance metrics.

Who are in the management team of Smruthi Organic?

The management team of Smruthi Organic includes E Purushotham (Chairman & Managing Director), E Swapnil (Joint Managing Director & CFO), and several independent directors: J H Ranade, K Ramaswamy, and Kashinath R Dhole, along with Urvashi D Khanna (Company Secretary) and E. Smruthi (Non-Executive Director). They are responsible for the company's strategic direction and operations.

The management team of Smruthi Organic includes the following individuals:<BR><BR>1. **E Purushotham** - Chairman & Managing Director<BR>2. **E Swapnil** - Joint Managing Director & CFO<BR>3. **J H Ranade** - Independent Director<BR>4. **K Ramaswamy** - Independent Director<BR>5. **Kashinath R Dhole** - Independent Director<BR>6. **Urvashi D Khanna** - Company Secretary & Compliance Officer<BR>7. **E. Smruthi** - Non-Executive & Non-Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

What does Smruthi Organic do?

Smruthi Organics Ltd is a micro-cap manufacturer of Active Pharmaceutical Ingredients (API) in the Pharmaceuticals & Biotechnology industry, with recent net sales of 29 Cr and a net profit of 3 Cr as of June 2026. The company was incorporated in 1989 and has a market cap of INR 160 Cr.

Overview: <BR>Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients (API) in the Pharmaceuticals & Biotechnology industry, classified as a micro-cap company.<BR><BR>History: <BR>Smruthi Organics Limited was incorporated in July 1989 as a Private Limited Company and was converted into a Public Limited Company in February 1995. The latest reported quarterly results show net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 29 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 3 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 160 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 21.00 <BR>Industry P/E: 37 <BR>Dividend Yield: 1.07% <BR>Debt Equity: 0.08 <BR>Return on Equity: 10.75% <BR>Price to Book: 2.19<BR><BR>Contact Details: <BR>Address: 165-A Balaji Bhavan 1st Floor, Railway Lines Solapur Maharashtra : 413001 <BR>Tel: 91-217-2310267/2310268 <BR>Email: changale@smruthiorganics.com <BR>Website: http://www.smruthiorganics.com

Who are the peers of the Smruthi Organic?

Peers of Smruthi Organic include CCME Global, Syschem (India), Achyut Healthcar, Parnax Lab, Panch.Organics, Auro Labs., and Quest Laborato. Smruthi Organic has average management risk and a 1-year return of 25.74%, higher than Syschem's -46.14% but lower than Achyut's 35.80%.

Peers: The peers of Smruthi Organic are CCME Global, Syschem (India), Achyut Healthcar, Parnax Lab, Panch.Organics, Auro Labs., and Quest Laborato.<BR><BR>Quality Snapshot: Excellent management risk is observed at Parnax Lab and Quest Laborato, while Average management risk is found at Smruthi Organic, Panch.Organics, and Auro Labs., and the rest have Below Average management risk. Good growth is seen at Syschem (India), Parnax Lab, and Quest Laborato, while Average growth is noted at Achyut Healthcar, and Below Average growth is present at Smruthi Organic, Panch.Organics, and Auro Labs., and the rest. Good capital structure is held by CCME Global, Syschem (India), Achyut Healthcar, Smruthi Organic, and the rest have either Excellent or Below Average capital structure.<BR><BR>Return Snapshot: Achyut Healthcar has the highest 1-year return at 35.80%, while Syschem (India) has the lowest at -46.14%, with Smruthi Organic's 1-year return at 25.74% being significantly higher than Syschem's but lower than Achyut's. Additionally, Syschem (India), Auro Labs., and Panch.Organics have negative six-month returns.

How big is Smruthi Organic?

As of 31st August, Smruthi Organics Ltd has a market capitalization of 160.00 Cr, with recent net sales of 112.24 Cr and a net profit of 7.41 Cr. The balance sheet as of March 2026 shows shareholder's funds of 73.51 Cr and total assets of 103.55 Cr.

As of 31st August, Smruthi Organics Ltd has a market capitalization of 160.00 Cr, categorizing it as a Micro Cap company.<BR><BR>For the latest four quarters, Smruthi Organics reported Net Sales of 112.24 Cr and a Net Profit of 7.41 Cr.<BR><BR>The latest reporting period for the balance sheet is March 2026, showing Shareholder's Funds of 73.51 Cr and Total Assets of 103.55 Cr.

Which are the latest news on Smruthi Organic?

Should I buy, sell or hold Smruthi Organics Ltd?

Are Smruthi Organics Ltd latest results good or bad?

Smruthi Organics Ltd's latest results are unfavorable, showing a 52.02% decline in net profit and a 23.63% drop in revenue year-on-year, despite a sequential revenue increase. Overall, the company's financial performance indicates operational challenges and underperformance compared to the pharmaceuticals sector.

Smruthi Organics Ltd's latest results indicate a challenging situation for the company. In the fourth quarter of FY26, the company reported a net profit of ₹1.07 crore, which is a significant decline of 52.02% year-on-year. Revenue also fell by 23.63% compared to the same quarter last year, totaling ₹29.09 crore. While there was a sequential improvement in revenue, with a 30.51% increase from the previous quarter, this does not offset the overall decline when viewed year-on-year.<BR><BR>The operating margin improved slightly to 13.03%, but the profit after tax (PAT) margin decreased to 3.68%, down from 5.85% in the same quarter last year. Additionally, the company's performance over the past year has been weak, with a return of only 1.41%, significantly underperforming the pharmaceuticals sector's average return of 10.24%.<BR><BR>Overall, the financial results reflect underlying operational challenges and a concerning trend of declining revenues and profits, which suggests that the latest results are not favorable for Smruthi Organics Ltd. Investors may need to be cautious given these indicators of financial health.

When is the next results date for Smruthi Organics Ltd?

The next results date for Smruthi Organics Ltd is 13 May 2026.

The next results date for Smruthi Organics Ltd is scheduled for 13 May 2026.

How has been the historical performance of Smruthi Organic?

Smruthi Organic's historical performance shows declining net sales and total operating income from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, despite a decrease in raw material costs and an increase in operating profit. Overall, the company has faced mixed financial results with fluctuating profits and cash flow.

Answer:<BR>The historical performance of Smruthi Organic shows a fluctuating trend in key financial metrics over the past several years.<BR><BR>Breakdown:<BR>Smruthi Organic's net sales have seen a decline from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, with a peak in March 2023. The total operating income followed a similar trend, dropping from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025. The raw material costs decreased significantly from INR 95.69 crore in March 2023 to INR 67.86 crore in March 2025, contributing to a reduction in total expenditure, which fell from INR 131.26 crore in March 2023 to INR 113.83 crore in March 2025. Operating profit (PBDIT) has also fluctuated, reaching INR 12.27 crore in March 2025, up from INR 9.89 crore in March 2023. However, profit before tax showed a slight increase from INR 4.49 crore in March 2023 to INR 4.90 crore in March 2025, while profit after tax decreased from INR 4.13 crore in March 2023 to INR 3.56 crore in March 2025. The company's total assets increased from INR 105.64 crore in March 2023 to INR 111.74 crore in March 2025, while total liabilities rose from INR 105.64 crore to INR 111.74 crore in the same period. Cash flow from operating activities improved to INR 9.00 crore in March 2025 from INR 12.00 crore in March 2023, indicating a mixed performance in cash generation. Overall, Smruthi Organic's financial performance reflects a challenging environment with varying trends in sales, profits, and expenses.

Who are the top shareholders of the Smruthi Organic?

The top shareholders of Smruthi Organic are mainly promoters, with Eaga Purushotham Malaiah holding 41.23%. The highest public shareholder is Smitha Gupta at 1.21%, while individual investors collectively own 28.81% of the shares.

The top shareholders of Smruthi Organic are primarily the promoters, with Eaga Purushotham Malaiah holding the largest stake at 41.23%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Smitha Gupta, who owns 1.21%. Additionally, individual investors collectively hold 28.81% of the shares.

Is Smruthi Organic overvalued or undervalued?

As of May 6, 2025, Smruthi Organic is considered undervalued with a PE ratio of 41.20 and an attractive valuation compared to peers, despite a recent 1-year return of -19.68%, while maintaining a strong long-term outlook with a 5-year return of 311.48%.

As of 6 May 2025, the valuation grade for Smruthi Organic has moved from expensive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued. Key ratios include a PE ratio of 41.20, an EV to EBITDA of 13.44, and a PEG ratio of 0.00, which suggests potential for growth relative to its price.<BR><BR>In comparison to its peers, Smruthi Organic's PE ratio is higher than Sun Pharma's 35.25 but lower than Divi's Lab's significantly high 79.33. Additionally, while Cipla has an attractive valuation with an EV to EBITDA of 15.93, Smruthi's lower EV to EBITDA indicates it may be undervalued relative to its earnings potential. Notably, despite recent underperformance with a 1-year return of -19.68% compared to the Sensex's 7.62%, the long-term outlook remains positive with a 5-year return of 311.48%.

What is the technical trend for Smruthi Organic?

As of May 12, 2025, Smruthi Organic's trend is mildly bearish, with conflicting signals from weekly indicators showing mild bullishness and monthly indicators remaining bearish.

As of 12 May 2025, the technical trend for Smruthi Organic has changed from bearish to mildly bearish. The weekly MACD and KST are both mildly bullish, indicating some positive momentum, while the monthly MACD and KST remain bearish. The Bollinger Bands also show a mildly bullish stance on the weekly timeframe but are bearish on the monthly. Daily moving averages indicate a mildly bearish trend. Overall, the current stance is mildly bearish, driven primarily by the conflicting signals between the weekly and monthly indicators.

What is the bonus history of the Smruthi Organic?

Smruthi Organic announced a 2:1 bonus issue on March 16, 2021, with a record date of March 17, 2021, allowing shareholders to receive two additional shares for every one share held.

Smruthi Organic has a bonus history that includes a 2:1 bonus issue announced on March 16, 2021. The record date for this bonus was March 17, 2021. This means that shareholders received two additional shares for every one share they held as of the record date. If you have any more questions about the company or its financial activities, feel free to ask!

Has Smruthi Organic declared dividend?

Yes, Smruthi Organics Ltd has declared a 15% dividend, amounting to ₹1.5 per share, with an ex-date of June 13, 2025. Despite recent volatility, the company has shown a strong recovery over the past five years, yielding a total return of 279.01%.

Smruthi Organics Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 13 Jun 25<BR><BR>Dividend Yield: 1.16%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -1.08%, the dividend return was 1.17%, resulting in a total return of 0.09%.<BR><BR>Over the past year, the price return was -21.76%, with a dividend return of 1.75%, leading to a total return of -20.01%.<BR><BR>In the 2-year period, the price return was -12.23%, while the dividend return was 3.86%, resulting in a total return of -8.37%.<BR><BR>For the 3-year period, the price return was -27.96%, the dividend return was 5.03%, culminating in a total return of -22.93%.<BR><BR>In the last 4 years, the price return was -50.94%, with a dividend return of 3.54%, resulting in a total return of -47.4%.<BR><BR>Finally, over the 5-year period, the price return was 252.55%, the dividend return was 26.46%, leading to a total return of 279.01%.<BR><BR>Overall, while Smruthi Organics Ltd has declared a dividend, the total returns over various periods show significant volatility, with negative returns in most periods except for the 5-year period, which indicates a strong recovery in the long term.